申请人:Coats J. Steven
公开号:US20050004163A1
公开(公告)日:2005-01-06
This invention is directed to 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives useful as δ-opioid or μ-opioid receptor modulators. Depending on their agonist or antagonist effect, the compounds are useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.
这项发明涉及3-(二芳基亚甲基)-8-氮杂双环[3.2.1]辛烷衍生物,可用作δ-阿片受体或μ-阿片受体调节剂。根据它们的激动剂或拮抗剂作用,这些化合物可用作镇痛剂、免疫抑制剂、抗炎药、用于治疗神经和精神疾病的药物、药物和酒精滥用的药物、治疗胃炎和腹泻的药物、心血管药物以及用于治疗呼吸系统疾病的药物。